硕世生物跌2.01%，成交额4534.44万元，主力资金净流出340.27万元

Core Viewpoint - The stock price of Shuoshi Biotechnology has experienced significant fluctuations, with a year-to-date increase of 84.68%, but recent trading shows a decline of 2.01% on October 30, 2023, indicating potential volatility in investor sentiment [1][2]. Company Overview - Shuoshi Biotechnology, established on April 12, 2010, and listed on December 5, 2019, is located in Taizhou, Jiangsu Province. The company specializes in the research, production, and sales of in vitro diagnostic reagents and related testing instruments [2]. - The main revenue sources for the company include diagnostic reagents (85.89%), purchased instruments and materials (7.19%), testing instruments (3.84%), testing services (2.24%), and others (0.84%) [2]. Financial Performance - For the period from January to September 2025, Shuoshi Biotechnology reported a revenue of 258 million yuan, reflecting a year-on-year decrease of 3.95%. The net profit attributable to the parent company was 3.15 million yuan, down 88.38% year-on-year [3]. - The company has distributed a total of 1.37 billion yuan in dividends since its A-share listing, with 285 million yuan distributed over the past three years [4]. Shareholder and Market Activity - As of October 20, 2023, the number of shareholders for Shuoshi Biotechnology was 7,620, a decrease of 0.94% from the previous period. The average circulating shares per person increased by 0.94% to 11,006 shares [3]. - The company has appeared on the "Dragon and Tiger List" once this year, with a net purchase of 19.78 million yuan on February 17, 2023, accounting for 26.20% of the total trading volume [2]. Market Sentiment and Trading Activity - On October 30, 2023, the stock price was reported at 75.73 yuan per share, with a trading volume of 45.34 million yuan and a turnover rate of 0.71%. The total market capitalization stood at 6.352 billion yuan [1]. - The net outflow of main funds was 3.40 million yuan, with large orders showing a buy of 12.05 million yuan (26.58%) and a sell of 15.78 million yuan (34.80%) [1].